Hospital Vithas La Salud

At Hospital Vithas La Salud, the Neurology department is actively involved in studies focused on nervous system diseases, especially focal epilepsy, refractory focal onset epilepsy, and adult focal seizures. The research is centered on evaluating new treatment options that may improve seizure control and help patients who continue to have seizures despite standard care.

• Testing new therapies for focal epilepsy and related seizure disorders
• Assessing safety and tolerability in adults with refractory epilepsy
• Measuring seizure reduction and treatment effectiveness

These trials reflect a strong interest in finding better ways to manage difficult-to-control epilepsy and improve daily outcomes for adults living with seizure disorders.

The site also contributes to research in oncology, with studies addressing metastatic castration-resistant prostate cancer. This work is aimed at comparing new treatment approaches with current physician-selected care to determine whether they can better delay disease progression and support improved cancer control.

• Evaluating treatment effectiveness in metastatic prostate cancer
• Comparing investigational therapy with standard clinician-chosen care
• Studying options for slowing cancer progression

Although the main focus at Hospital Vithas La Salud is neurology, this neoplasm research adds an important cancer-focused dimension to the site’s clinical trial portfolio.

Several ongoing studies at the center are examining emerging medicines for focal onset seizures and primary generalized tonic-clonic seizures. The goal is to better understand how these therapies perform as add-on treatments, while also confirming their safety for adults already using standard anti-seizure medicines.

• Supporting treatment development for adult epilepsy
• Exploring add-on therapy for persistent seizures
• Building evidence on safety and tolerability in neurological disease

With multiple investigators involved, the research program shows sustained activity in epilepsy care and a continued effort to improve options for people whose seizures remain hard to control.